Traws Pharma, Inc.

TRAW · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$55-$19-$19-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$7-$0$1-$4
Other Non-Cash$31$1$1$0
Operating Cash Flow-$30-$18-$16-$19
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions-$4$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$4-$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$34$0$0$55
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$34$0$0$56
Forex Effect-$0$0-$0-$0
Net Chg. in Cash$1-$18-$16$36
Supplemental Information
Beg. Cash$21$39$55$19
End Cash$21$21$39$55
Free Cash Flow-$30-$18-$16-$19
Traws Pharma, Inc. (TRAW) Financial Statements & Key Stats | AlphaPilot